UroGen Pharma Ltd. (URGN)
USD 10.79
(-4.77%)
USD 10.79
(-4.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 82.71 Million | 64.35 Million | 48.04 Million | 11.79 Million | 18 Thousand | 1.12 Million |
| Cost of Revenue | 9.36 Million | 7.65 Million | 5.15 Million | 1 Million | - | 1.8 Million |
| Gross Profit | 73.35 Million | 56.7 Million | 42.88 Million | 10.79 Million | 18 Thousand | -675 Thousand |
| Operating Expenses | 138.88 Million | 135.74 Million | 135.17 Million | 137.52 Million | 109.49 Million | 76.5 Million |
| Selling, General and Administrative Expenses | 93.27 Million | 82.83 Million | 87.53 Million | 90.21 Million | 60.19 Million | 39.57 Million |
| Research and Development Expenses | 45.61 Million | 52.9 Million | 47.64 Million | 47.31 Million | 49.29 Million | 36.93 Million |
| Other Expenses | - | 72 Thousand | - | - | -284 Thousand | - |
| Cost and Expenses | 148.24 Million | 143.39 Million | 140.33 Million | 138.53 Million | 109.49 Million | 78.3 Million |
| Operating Income | -65.53 Million | -79.04 Million | -92.29 Million | -126.73 Million | -109.47 Million | -77.18 Million |
| Interest Expense | 14.71 Million | 8.43 Million | 17.44 Million | 357 Thousand | 284 Thousand | - |
| Income Tax Expense | 3.92 Million | 1.13 Million | 1.44 Million | 3.37 Million | -4.61 Million | 125 Thousand |
| Earnings before Tax | -98.32 Million | -108.02 Million | -109.37 Million | -125.11 Million | -105.14 Million | -75.53 Million |
| Net Income | -102.24 Million | -109.16 Million | -110.82 Million | -128.48 Million | -100.53 Million | -75.65 Million |
| Earnings Per Share Basic | -3.55 | -4.79 | -4.96 | -5.90 | -4.90 | -4.80 |
| Earnings Per Share Diluted | -3.55 | -4.79 | -4.96 | -5.90 | -4.90 | -4.80 |
| Weighted Average Shares Outstanding | 28.83 Million | 22.8 Million | 22.34 Million | 21.78 Million | 20.52 Million | 15.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.83 Million | 22.8 Million | 22.34 Million | 21.78 Million | 20.52 Million | 15.75 Million |
| Gross Margin | 0.89 | 0.88 | 0.89 | 0.91 | 1.00 | -0.60 |
| EBIT Margin | -0.77 | -1.21 | -1.56 | -10.74 | -6008.56 | -68.42 |
| Profit Margin | -1.24 | -1.70 | -2.31 | -10.89 | -5585.00 | -67.07 |
| EBITDA | -63.83 Million | -78.03 Million | -90.15 Million | -122.7 Million | -108.15 Million | -77.18 Million |
| Earnings Before Tax Margin | -0.79 | -1.23 | -1.92 | -10.74 | -6082.11 | -68.42 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 25.2 Million | 21.84 Million | 18.78 Million | 82.71 Million | 23.53 Million | 20.85 Million |
| Cost of Revenue | 2.45 Million | 2.22 Million | 1.72 Million | 9.36 Million | 2.28 Million | 2.36 Million |
| Gross Profit | 22.75 Million | 19.61 Million | 17.05 Million | 73.35 Million | 21.24 Million | 18.48 Million |
| Operating Expenses | 40.29 Million | 45.45 Million | 42.79 Million | 138.88 Million | 35.85 Million | 31.98 Million |
| Selling, General and Administrative Expenses | 28.94 Million | 30.05 Million | 27.29 Million | - | 24.55 Million | 21.75 Million |
| Research and Development Expenses | 11.35 Million | 15.4 Million | 15.49 Million | - | 11.3 Million | 10.23 Million |
| Other Expenses | - | -14 Thousand | -183 Thousand | 838 Thousand | 812 Thousand | 71 Thousand |
| Cost and Expenses | 42.74 Million | 47.68 Million | 44.52 Million | 148.24 Million | 38.13 Million | 34.35 Million |
| Operating Income | -17.54 Million | -25.83 Million | -25.74 Million | -65.53 Million | -14.6 Million | -13.5 Million |
| Interest Expense | -2.72 Million | 3.46 Million | 2.44 Million | 36.26 Million | 9.09 Million | 3.81 Million |
| Income Tax Expense | -91 Thousand | 38 Thousand | 54 Thousand | 3.92 Million | 3.85 Million | -9000.00 |
| Earnings before Tax | -23.58 Million | -33.36 Million | -32.23 Million | -98.32 Million | -22.16 Million | -21.88 Million |
| Net Income | -23.67 Million | -33.4 Million | -32.28 Million | -102.24 Million | -26.01 Million | -21.87 Million |
| Earnings Per Share Basic | -0.00 | -0.91 | -0.97 | - | -0.72 | -0.68 |
| Earnings Per Share Diluted | -0.00 | -0.91 | -0.97 | - | -0.72 | -0.68 |
| Weighted Average Shares Outstanding | 43.1 Billion | 36.82 Million | 33.37 Million | 28.83 Million | 36.15 Million | 32.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.1 Billion | 36.82 Million | 33.37 Million | 28.83 Million | 36.15 Million | 32.29 Million |
| Gross Margin | 0.90 | 0.90 | 0.91 | 0.89 | 0.90 | 0.89 |
| EBIT Margin | -0.70 | -1.17 | -1.35 | - | -0.60 | -0.58 |
| Profit Margin | -0.94 | -1.53 | -1.72 | -1.24 | -1.11 | -1.05 |
| EBITDA | -17.54 Million | -25.57 Million | -25.38 Million | - | -14.18 Million | -12.17 Million |
| Earnings Before Tax Margin | -0.70 | -1.18 | -1.37 | -0.79 | -0.62 | -0.65 |
OCEAW
CYIENT
ROOPAIND
BCCLF
OWLI
BBOX